G, L., Y, J., Y, J., J, Z., C, J., Z, Z., . . . Q, L. (2022). A Comparison of the Efficacy of 5 mg Olanzapine and Aprepitant in the Prevention of Multiple-Day Cisplatin Chemotherapy-Induced Nausea and Vomiting. International journal of clinical practice, 2022, 5954379. https://doi.org/10.1155/2022/5954379
Chicago Style (17th ed.) CitationG, Liu, et al. "A Comparison of the Efficacy of 5 mg Olanzapine and Aprepitant in the Prevention of Multiple-Day Cisplatin Chemotherapy-Induced Nausea and Vomiting." International Journal of Clinical Practice 2022 (2022): 5954379. https://doi.org/10.1155/2022/5954379.
MLA (9th ed.) CitationG, Liu, et al. "A Comparison of the Efficacy of 5 mg Olanzapine and Aprepitant in the Prevention of Multiple-Day Cisplatin Chemotherapy-Induced Nausea and Vomiting." International Journal of Clinical Practice, vol. 2022, 2022, p. 5954379, https://doi.org/10.1155/2022/5954379.